Q32 Bio Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | — | $26.5M |
| Jun 2017 | — | — | $20.4M |
| Sep 2017 | — | — | $97.8M |
| Dec 2017 | — | $-39.5M | $51.6M |
| Mar 2018 | — | $-49.2M | $46.2M |
| Jun 2018 | — | $227.6M | $95.0M |
| Sep 2018 | — | $214.2M | $36.0M |
| Dec 2018 | — | $196.4M | $38.2M |
| Mar 2019 | — | $174.3M | $40.8M |
| Jun 2019 | — | $284.7M | $115.6M |
| Sep 2019 | — | $257.8M | $77.6M |
| Dec 2019 | — | $258.5M | $53.8M |
| Mar 2020 | — | $226.5M | $143.4M |
| Jun 2020 | — | $194.7M | $167.6M |
| Sep 2020 | — | $170.2M | $178.0M |
| Dec 2020 | — | $196.0M | $217.4M |
| Mar 2021 | — | $200.8M | $104.4M |
| Jun 2021 | — | $224.6M | $116.3M |
| Sep 2021 | — | $198.6M | $95.8M |
| Dec 2021 | — | $169.7M | $108.4M |
| Mar 2022 | — | $266.3M | $248.1M |
| Jun 2022 | — | $240.3M | $176.2M |
| Sep 2022 | — | $209.1M | $43.2M |
| Dec 2022 | — | $-130.7M | $34.0M |
| Mar 2023 | — | $-137.2M | $31.4M |
| Jun 2023 | — | $-142.7M | $20.1M |
| Sep 2023 | — | $-156.5M | $36.3M |
| Dec 2023 | — | $-182.9M | $25.6M |
| Mar 2024 | — | $48.8M | $115.5M |
| Jun 2024 | — | $33.5M | $97.7M |
| Sep 2024 | — | $18.3M | $89.1M |
| Dec 2024 | — | $5.7M | $78.0M |
| Mar 2025 | — | $-4.0M | $65.5M |
| May 2025 | — | $4.0M | — |
| Jun 2025 | — | $-12.2M | $54.8M |
| Sep 2025 | — | $-18.4M | $49.0M |
| Dec 2025 | — | $42.0M | $48.3M |
| Mar 2026 | — | $46.3M | $50.8M |
| Jun 2026 | — | $105.9M | $106.3M |